These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

367 related articles for article (PubMed ID: 20101550)

  • 41. [Echinocandins in invasive candidiasis].
    Glöckner A; Cornely OA
    Med Klin (Munich); 2008 Jun; 103(6):397-405. PubMed ID: 18548209
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Epidemiology, diagnosis and treatment of fungal respiratory infections in the critically ill patient.
    Garnacho-Montero J; Olaechea P; Alvarez-Lerma F; Alvarez-Rocha L; Blanquer J; Galván B; Rodriguez A; Zaragoza R; Aguado JM; Mensa J; Solé A; Barberán J
    Rev Esp Quimioter; 2013 Jun; 26(2):173-88. PubMed ID: 23817660
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Fungal sepsis: optimizing antifungal therapy in the critical care setting.
    Lepak A; Andes D
    Crit Care Clin; 2011 Jan; 27(1):123-47. PubMed ID: 21144990
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Fungal infections in ICU patients: epidemiology and the role of diagnostics.
    Morace G; Borghi E
    Minerva Anestesiol; 2010 Nov; 76(11):950-6. PubMed ID: 21102391
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Antifungal treatment options in the critically ill patient].
    Zaragoza R; Pemán J
    Rev Iberoam Micol; 2012; 29(2):108-13. PubMed ID: 22463788
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Advances in the diagnosis and treatment of yeast infections: role of the new antifungal agents].
    Pemán J; Almirante B
    Enferm Infecc Microbiol Clin; 2008 Nov; 26 Suppl 13():38-46. PubMed ID: 19100166
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Role of anidulafungin in critically ill patients].
    Borges Sá M; Garnacho Montero J
    Enferm Infecc Microbiol Clin; 2008 Dec; 26 Suppl 14():35-43. PubMed ID: 19572433
    [TBL] [Abstract][Full Text] [Related]  

  • 48. New antifungal agents for the treatment of candidaemia.
    Muñoz P; Guinea J; Rojas L; Bouza E
    Int J Antimicrob Agents; 2010 Dec; 36 Suppl 2():S63-9. PubMed ID: 21129925
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Issues in the design and interpretation of antifungal drug trials in the critically ill.
    Ostrosky-Zeichner L
    Curr Opin Infect Dis; 2009 Dec; 22(6):564-7. PubMed ID: 19726983
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Design and use of Candida scores at the intensive care unit.
    Kratzer C; Graninger W; Lassnigg A; Presterl E
    Mycoses; 2011 Nov; 54(6):467-74. PubMed ID: 21535452
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Treatment of fungal infections in surgical patients using conventional antifungals.
    De Pauw BE; Donnelly JP; Kullberg BJ
    J Chemother; 1999 Dec; 11(6):494-503. PubMed ID: 10678791
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Pharmacokinetic evaluation of fluconazole in critically ill patients.
    Sinnollareddy M; Peake SL; Roberts MS; Playford EG; Lipman J; Roberts JA
    Expert Opin Drug Metab Toxicol; 2011 Nov; 7(11):1431-40. PubMed ID: 21883033
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Management of candidaemia and invasive candidiasis in critically ill patients.
    Chahoud J; Kanafani ZA; Kanj SS
    Int J Antimicrob Agents; 2013 Jun; 42 Suppl():S29-35. PubMed ID: 23664579
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Invasive candidiasis in critically ill adult patient].
    Tobar A E; Silva O F; Olivares C R; Gaete G P; Luppi N M
    Rev Chilena Infectol; 2011 Feb; 28(1):41-9. PubMed ID: 21526285
    [TBL] [Abstract][Full Text] [Related]  

  • 55. How to select an antifungal agent in critically ill patients.
    Dimopoulos G; Antonopoulou A; Armaganidis A; Vincent JL
    J Crit Care; 2013 Oct; 28(5):717-27. PubMed ID: 24018296
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Nosocomial fungal infections: epidemiology, diagnosis, and treatment.
    Perlroth J; Choi B; Spellberg B
    Med Mycol; 2007 Jun; 45(4):321-46. PubMed ID: 17510856
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Why Candida sepsis should matter to ICU physicians.
    Skrobik Y; Laverdiere M
    Crit Care Clin; 2013 Oct; 29(4):853-64. PubMed ID: 24094381
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Invasive candidiasis in the intensive care unit.
    Ostrosky-Zeichner L; Pappas PG
    Crit Care Med; 2006 Mar; 34(3):857-63. PubMed ID: 16505666
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Early antifungal intervention strategies in ICU patients.
    Eggimann P; Ostrosky-Zeichner L
    Curr Opin Crit Care; 2010 Oct; 16(5):465-9. PubMed ID: 20827073
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Role of probiotics in prevention of Candida infection in critically ill children.
    Kumar S; Singhi S
    Mycoses; 2013 May; 56(3):204-11. PubMed ID: 23176162
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.